stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Arcus Biosciences IncRCUS
$17.431.91%-0.34

Arcus Biosciences Inc (RCUS)

Arcus Biosciences Inc stock is traded at $17.43, with a volume of 1,138,744. It is down -1.91% in the last 24 hours and down -22.57% over the past month. Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
Previous Close:
$17.77
Open:
$17.58
24h Volume:
1,138,744
Relative Volume:
0.83
Market Cap:
$2.51B
Revenue:
$236.00M
Net Income/Loss:
-$369.00M
P/E Ratio:
-
EPS:
-$3.18
Net Cash Flow:
-$489.00M
1W Performance:
-4.65%
1M Performance:
-22.57%
6M Performance:
-30.28%
1Y Performance:
-11.93%
1-Day Range:
$17.03$17.72
1-Week Range:
$17.03$19.27
52-Week Range:
$17.03$31.74

Arcus Biosciences Inc Stock (RCUS) Company Profile

Name
Arcus Biosciences Inc
Phone
(510) 694-6200
Address
3928 POINT EDEN WAY, HAYWARD, CA, USA
Employee
601
Next Earnings Date
-
Latest SEC Filings
SEC
RCUS's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Arcus Biosciences Inc Stock (RCUS) Financials Data

Similar to RCUS